Honestly, it took me a while to trust the current management after the clear securities violations and cooking the books with the past CEO. Higgins took over a clearly struggling company he cleaned house ,cut costs ,found a new business model (that is starting to drive significant profits) and is just starting to tip the scales into becoming a well known small cap . It's truly a major turnaround story that Higgins deserves full credit for. The only complaint I have is if the stock gets to the 90 range(soon)a split is clearly going to happen.kryprolis positive p3 is coming in the next 3 months which will yield a long term catalyst for ligand stock. There are so many catalyst in the near term I cannot even remember them all. Good luck longs.
Didn't u sell before earnings? Bad timing we clearing are in a new trading range with the upward breakout possible after the Roth conference. Would like Higgins to split the stock . But the past two years I have no issue with management we are where we should be.
80 soon.. Still not back to the 130.00 all time high. This company is a model for diversification ( multiple drug pipeline) , r& d ( never had a FDA decline ) , multiple revenue streams with higher royalty rates based on sales , very lean expense with no debt (all debt will be retired in 6 months) . No patent expiration until 2020's . 3 blockbusters already being marketed. Extremely high growth rates with no expense increase. Great business model !! We should see several large mm and institutions buying over the next year. Still a low profile company with 21 employees!! Wow
I couldn't agree more 100pps is very reasonable given the projections and added Growth revenue that is expected. Ligand is just starting to hit its stride..
We will have another blow out year !! 60 -64 million is conservative Kryprolis P3 is coming in the June timeframe orders will be huge the 2nd half I would estimate close to 70 million by year end.
Kyprolis results soon. If Kyprolis results are positive we will blow the 2014 estimates away..
Really !!! its only half way to pre split levels!! You are not familiar with the business model and profits going forward thru 2014 -15 .By 2015 we will be in the 2.50-3.00 range . that puts us over 100pps easily.
See you higher next year . Congrats longs . This re affirms the business model is producing significant profits for shareholders.
Looking for above estimate results. Increased 2014 results .. Doesn't matter where we will be after earnings the key is where we will be in 6 months 12 months. Shorts r done!! Congrats longs
My take is the forward looking projections. With the Onxx integration what does Amgen see as far as Kyprolis traction over the next 2 quarters. We may see increases, but the market potential is in the P3 results. Good luck longs!!! new highs soon
Ligand is a great company went from 51 straight to 65 with a blink of an eye. Profit from the run up appears to be overdone. Always happens!! We should settle in the 60 range looking for the bounce off the bottom here so we can have a nice new trading base. Good luck longs catalysts everywhere in the next 3-6 months!!
Just amazing 2013 and a lot more to go.. 2014 is more of the same and over 100 million in 2015 . The Higgins model is paying off for the longs. Waiting for a Mid Cap Pharma to make a offer. How about a stock split? or the spin off of the two business . Lots of directions which are very attractive to shareholders. Good luck longs. Obama for a 3 term!! lol